BackLisata Therapeutics Overview

Lisata Therapeutics Current Cash

Track Lisata Therapeutics's current cash ($10M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$10.44M
↓ 37.97% YoYΔ $-6.39M vs prior year quarter

Peer trimmed avg / median

Loading

Lisata Therapeutics Current Cash History

Loading

Lisata Therapeutics vs. peers: Current Cash Comparison

Loading

Lisata Therapeutics Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Lisata Therapeutics (LSTA) FAQ

Lisata Therapeutics (LSTA) currently reports a current cash of $10M as of June 2026. That compares with $17M in the prior-year period — down 38.0% year over year. Use the charts on this page to explore Lisata Therapeutics's current cash history and peer comparisons.

Lisata Therapeutics's current cash decreased from $17M to $10M — a 38.0% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Lisata Therapeutics reported $10M in current cash as of June 2026. That compares with $17M in the prior-year period — down 38.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $10M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Lisata Therapeutics, and consider following LSTA for alerts when major investors trade the stock.

Lisata Therapeutics is classified in the Healthcare sector. On current cash, it currently shows $10M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LSTA with unrelated industries.